Readily Diagnostics
Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.
~$970KGates Foundation grant
ParticipantGF
Gates Foundation
Activity from announced rounds
Activity in this selectionUndisclosed
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $85M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionProFound Therapeutics
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
$35MStrategic
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedHeritable Agriculture
Develops AI-driven crop improvement solutions for climate-resilient crops
$5MGrant
Role not disclosedQure.ai
Develops AI-powered diagnostic solutions for early detection and care management of diseases
UndisclosedGrant
Role not disclosed